OpenAI acquires Orchestra Bio to expand its biotech businessMachine translation
Automatically verified and published · Generated and evidence-checked automatically; not reviewed by a human.
OpenAI says it will add Orchestra Bio’s team and technology to Rosalind, its AI model for life sciences research, and Rosalind Workbench, a tool intended to help researchers plan experiments and analyze results.
The complete source text is not yet available.
Read at the original source